Omega Healthcare Investors, Inc. – Consensus ‘hold’ rating and .4% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Omega Healthcare Investors, Inc. with ticker code (OHI) now have 13 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The range between the high target price and low target price is between 36 and 28 and has a mean target at $32.12. Given that the stocks previous close was at $32.00 this would imply there is now a potential upside of .4%. There is a 50 day moving average of $31.13 and the 200 moving average now moves to $29.27. The total market capitalization for the company now stands at 7.65B. The stock price is currently at: 31.68 USD

The potential market cap would be $7,673,877,080 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 27.31, revenue per share of 3.63 and a 2.33% return on assets.

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through the segment, which consists of investments in healthcare-related real estate properties located in the United States and the United Kingdom. The Company’s core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). The Company’s portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. Its portfolio of real estate investments includes over 926 healthcare facilities, located in 42 states and the United Kingdom that are operated by 67 third-party operators.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search